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A B S T R A C T
This article is inspired by the social life of methods approach, joining a movement among social scientists
engaging with ‘big data’ to contribute to methodological innovation and conceptual development in research and
knowledge translation. It explores human-drug associations using a computational tool, Medicine Radar,
meanwhile raising questions about the ways a digital device pushes us to rethink how drugs are known in the
everyday. Medicine Radar is an apparatus for exploring human-drug associations by means of Suomi24
(Finland24) data, containing 19 million health-related online posts spanning a period of 16 years. Using deﬁned
markers, Medicine Radar sorts the medicine talk in health-related discussions, thereby assisting us to ‘see’ the
actions of the drug and human responses to them. This kind of approach distances the drug from the illness
experience, drawing attention to the private details of the human-drug relationship. The empirical analysis
separates three areas of antidepressant use: articulations of reactions, stabilizing the life eﬀects of drugs and
coming to terms with antidepressants. Together, the online posts urge us to think of everyday experience where
the eﬀects of drugs – intended or unintended – are always lived. The side eﬀects of antidepressants, including
drowsiness, ravenous hunger, loss of sexual desire and emotional numbness, become life eﬀects. As will be
demonstrated, the move from conceptualizing such fallout as side eﬀects to understanding them as life eﬀects
has political ramiﬁcations. The computation tool adds collective weight to antidepressant experiences and calls
for politicizing their eﬀects on life.
1. Introduction
A research focus on how methods translate empirical data and
promote some forms of knowing and knowledge formation at the ex-
pense of others has become newly revitalized by a research stream fo-
cusing on ‘the social life of methods’ (Savage, 2013). This approach
raises questions about the historical, cultural, social and political ra-
miﬁcations of methods and methodological development, recognizing
that the expansion of digital data gathering and use, mediated by digital
tools and devices, has made these questions particularly timely (Marres
and Weltevrede, 2013; Ruppert et al., 2013). Ruppert et al. (2013, 25)
argue that digital devices rework ‘the very assumptions of social science
methods’ by participating in the processes of ‘seeing’ and ‘knowing’ the
studied phenomenon.
This article is inspired by the social life of methods approach,
joining a movement among social scientists engaging with ‘big data’ to
contribute to methodological innovation and conceptual development
in research and knowledge translation (Bates et al., 2016; Kitchin,
2014; Laaksonen et al., 2017; Rapp, 2016). The reported study explores
human-drug associations using a computational tool, Medicine Radar,
raising questions about the ways a digital device pushes us to rethink
how drugs are known in the everyday. Medicine Radar is a purpose-
built apparatus (Ruppert et al., 2013, 30) for exploring human-drug
associations by means of Suomi24 (Finland24) data, containing 19
million health-related online posts that span a period of 16 years. As an
apparatus that traces a drug through the millions of messages and
renders its actions visible, Medicine Radar participates in the debate
over how a digital tool allows us to access (or not) health-related dis-
cussions that are intimate and collectively shared. By condensing views
to the lived experience of medication use, an unobtrusive digital tool
can aid in overcoming some of the diﬃculties of studying ethically
sensitive and temporally shifting aspects of everyday use of drugs and
pharmaceuticals (Petersen et al., 2018). Using deﬁned markers, Medi-
cine Radar sorts ‘medicine talk’ in health-related discussions, thereby
assisting us to ‘see’ the actions of the drug and human responses to
those actions. This kind of approach distances the drug from the actual
illness experience with the consequence that we are no longer dealing
with illnesses or medication trajectories, but articulations of drug ex-
periences.
Everyday drug use has been explored in the ﬁelds of sociology,
anthropology, social psychology, the medical humanities and STS.
Research highlights the overall expansion of pharmaceuticals in the
https://doi.org/10.1016/j.socscimed.2019.112368
Received 7 January 2019; Received in revised form 6 June 2019; Accepted 11 June 2019
E-mail address: minna.ruckenstein@helsinki.ﬁ.
Social Science & Medicine 235 (2019) 112368
Available online 13 June 2019
0277-9536/ © 2019 The Author. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license 
(http://creativecommons.org/licenses/BY-NC-ND/4.0/).
T
everyday and practices connected with drug use (Abraham, 2010;
Martin, 2007; Will and Weiner, 2015). Explorations of patients' and
consumers' views on medications focus on the interpretative repertoires
of drugs (Lumme-Sandt et al., 2000), and the willingness, reluctance
and refusal to engage with suggested courses of medical treatment
(Gibson et al., 2014; Pound et al., 2005). Within the clinical framework,
patients are expected to follow the instructions for the use of medica-
tion, but in the everyday people tinker with drugs and may substitute
other treatments (Will and Weiner, 2015; Weiner and Will, 2016): ex-
perimenting with medications and dosages and modifying and alter-
nating their use of drugs in order to alleviate symptoms of illness or side
eﬀects of medication. While using drugs, the doctor is not the only ally;
drug consumers rely on the advice and support of family, friends, col-
leagues and online peer and mentors (McCosker, 2018; Tucker and
Goodings, 2017). The knowledges and practices regarding drug use and
their eﬀects can grow into a detailed ‘folk pharmacology’ (Southgate
and Hopwood, 2001).
The exploration of medicine talk by means of a digital tool adds a
focus to scholarly work that highlights the recurring features of human-
drug encounters, exposing how nameless allies and peer mentors share
information about the known side eﬀects of drugs, and encourage and
caution others in their medicinal encounters. As previous research has
indicated, online forums might be preferred to face-to-face encounters
when discussing sensitive and stigmatized health-related topics
(Petersen et al., 2018; Tanis, 2008). While the ideal goal of drug use is
straight-forward – to alleviate symptoms and illness – the anonymous
posts in Suomi24 data address a broad range of issues concerning
medication, both those leading up to the decision to take it and also
after receiving the prescription. As agents of health and wellbeing,
drugs are supposed to exercise mechanical and linear causality. When a
painkiller eases a headache, or an allergy medicine eases the symptoms
of hay fever, it means that our bodies are being worked on in exactly the
right way. The more mechanical the causality drugs oﬀer, the more
competent they appear in their agency. Competent drugs are quickly
adopted; they are precise and eﬃcient, reinforcing modern notions of
control and allowing us to govern the processes and entities of human
lives. Yet not all drugs, or the same drugs universally, have such me-
chanical and straight-forward agency – think of warfarin, for instance
(Dickson, 2018), with the known unintended and unwanted agencies of
medicines being listed in the leaﬂets inside drug packages as side ef-
fects. Drugs might also have no eﬀect on certain bodies, or their agency
might diminish over time and be complicated by ‘placebo eﬀects’ or
factors such as alcohol, smoking, exercise, general health status, weight
and age.
When delving into drug talk with the aid of Medicine Radar, anti-
depressants appeared to be exceptionally unpredictable in their agency.
In Finland, as in many other countries, antidepressant use is fairly
common (with approximately 7 percent of the population using them
yearly). After reading some hundreds of posts focusing on an anti-
depressant sold in Finland under the label Mirtazapin (previously
Remeron), it became obvious that, in the case of antidepressants, the
causality that the Medicine Radar aids in exploring is ‘emergent’
(Connolly, 2004), rather than mechanic. Emergent causality refers to
medicinal agencies that are not known in detail prior to eﬀects that
appear over time, suggesting ‘a melting of cause and eﬀect’ (Bennett,
2010, 33), the impossibility of tracing a linear sequence of events in
terms of causality. In order to not to limit the discussion to one drug,
exploration was expanded to another antidepressant (Venlafaxin).
Based on the posts, antidepressant engagements are characterized by
processes of ‘trial and error’ (Schoﬁeld et al., 2011, 145) that can be
relatively short-lived, or last weeks or months. Not only do anti-
depressants act diﬀerently on diﬀerent bodies, they may operate at
diﬀerent intensities within the same body over time (Bennett, 2010,
41–24). Thus they collaborate with humans in ways that cannot be fully
anticipated, giving rise to various kinds of eﬀects that might intensify
each other, or work in diﬀerent directions (Wilson, 2008).
In the following, the goal is to explore emergent causality by means
of online comments, and demonstrate ways in which humans respond
to an unpredictable nonhuman agent. The decision to take prescription
drugs can mean entering into collaboration with a medicinal agent
whose eﬀects and actions cannot be predicted or controlled. By at-
tending to emergent causality, a tool like Medicine Radar can aid us in
seeing how people live with and respond to the ‘other’ agencies of
medications, discussed under the rubric of the placebo or side eﬀects, or
framed as failures of medical treatment. The purpose-built apparatus
oﬀers a window onto human-drug associations that are deemed worthy
of sharing with others online. Comments on antidepressants – which
might have been written when actively suﬀering from serious side ef-
fects – suggest that drugs can either enhance or weaken the power of
the human will and human behavior. A focus on these instances is a
tribute to the silent work of enduring the eﬀects of antidepressants; the
posts, traced with the aid of Medicine Radar, urge us to consider the
everyday where the eﬀects of drugs – whether intended or unintended –
are always lived. The side eﬀects of antidepressants, including drow-
siness, ravenous hunger, itching, sores, loss of sexual desire and emo-
tional numbness, become life eﬀects. As will be argued, this move from
regarding such outcomes as side eﬀects to acknowledging them as life
eﬀects has political ramiﬁcations. Following Bennett (2010), the in-
consistent nature of antidepressants calls for politicizing their eﬀects on
life.
1.1. Developing a radar
In spring 2017, together with a data scientist colleague, Krista
Lagus, we approached the technology company, Futurice's Chilicorn
Fund, a corporate social responsibility program, with a proposal to
develop a research tool for exploring medication talk in the Suomi24
data. Originally a by-product of a generic discussion forum, the
Suomi24 data – consisting of anonymous posts covering themes from
politics and religion to health and travel (Lagus et al., 2016) – had
grown on the company servers for over a decade, gaining new life and
purpose when the company decided to open the proprietary data for
research purposes. Health-related conversations include tens of topics,
ranging from addiction and eating disorders to illnesses such as dia-
betes, depression, migraine or skin diseases. Less than 10 percent of the
users of the Suomi24 forum are registered and most writers reveal little
about their background. Consequently, we do not know the age or le-
vels of education of people writing about their antidepressant experi-
ences or whether they live in urban or rural environments. Even the
well-known gendered aspects of depression remain unsubstantiated by
the posts (Fullagar & O'Brien, 2012). Despite its massive volume of
millions of comments, Suomi24 data are ‘thin’ on personal and collec-
tive contextual features, particularly when compared to qualitative
research data generated by means of interviews and ethnographic ac-
counts. The thinness of the data requires careful consideration of how to
make the material thick enough to be of value for research.
The characteristics of the Suomi24 data have been discussed in
more detail elsewhere (Lagus et al., 2016), emphasizing ‘the broken-
ness’ in terms of its gaps and absences (Pink et al., 2018). Despite these
ﬂaws and limitations, the dataset is unique in its size and openness, and
tens of researchers have been, or are currently working with it (Lagus
et al., 2018a; Pakkasvirta, 2018; Ylisiurua, 2017). A particular strength
of big data is that they can be used for building digital devices that can
participate in the processes of seeing and knowing digital traces in
online conversations. From this perspective, the Suomi24 data enable
the testing and probing of the social life of methods approach, querying
how digital devices aid us in seeing the subject matter of research,
thereby pushing us to rethink what is already known.
Futurice's team, Atte Juvonen and Chang Rajani, started the data
work by identifying medicine and symptom concepts in the millions of
online posts. The idea was to use medicine words as ‘markers’ for
gaining traction on the data. The beneﬁt of focusing on medicine words
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in Finland is that they are typically of foreign origin and not easily
confused with other Finnish words. Concept-oriented analysis of the
Suomi24 data had already been undertaken with emotion vocabularies
by Krista Lagus, so our team had a good understanding of how to
generate concept vocabularies with this particular dataset (Lagus et al.,
2018a, 2018b). We were unable to locate symptom word lists to support
the forming of concept vocabularies, but medicine word lists could be
found online. They were insuﬃcient, however, as the same medicine
can have many marketing labels and medicines are given nicknames
and abbreviations. All such variations needed to be included in the
vocabulary to capture as much medicine talk as possible.
The forming of vocabularies was supported with a ‘theme word’
collector, developed by the data analyst team in Futurice, working
through so-called ‘seed words’ (Lagus et al., 2018b) with Word2Vec
(Mikolov et al., 2013) to aid in ﬁnding semantically and syntactically
similar words. The Suomi24 discussions also cover substances such as
cannabis and magnesium, so they were included in the drug vocabulary
because, in the same way as medication, they are discussed online as
remedies. In fact, cannabis is the most mentioned drug in the posts
(Fig. 1). The vocabularies were ﬁnalized by adding common words that
seemed to be missing from the list of key words, with some manual
editing, and consist of approximately 1500 medicines and medicine-like
concepts and 500 symptoms, with tens of thousands of surface forms.
During the formation of vocabularies the data analyst team dis-
covered that drug talk often includes dosages and an additional dosage
feature was added to the machine learning approach (Fig. 2). Overall,
the vocabulary work was more prone to omissions and errors in the case
of symptoms than medicines, suggesting that Medicine Radar works
more accurately in tracing medications than symptoms. The theme
word collector and the vocabularies used for developing Medicine
Radar have been published as open source, and the web interface of
Medicine Radar (https://laaketutka.ﬁ/) is publicly open, and provides
background information on how medicines and symptoms are corre-
lated. The interface allows anyone to conduct a search with a medicine
keyword and thereby also participate in the discussion concerning the
ﬁndings of this study.
Medicine Radar's interface visualizes patterns, particularly with the
dosage feature, in the way drugs are discussed online. This quality was
highlighted when the device was named ‘a radar’, a system for detecting
the presence, direction and distance of medication vocabulary in rela-
tion to dosages. With its computation powers, Medicine Radar eﬃ-
ciently demonstrates the volume of posts discussing antidepressants
(13,052) or SSRIs (7756). In order to have enough posts mentioning a
speciﬁc drug (in this study Mirtazapin/Remeron and Venlafaxin), the
dataset needs to be large, emphasizing the uniqueness of the 19 million-
post dataset on which we have worked. With this kind of proﬁciency,
the digital tool participates in ‘seeing’ in a way a human cannot,
competently spotting only those messages that mention a group of
drugs, or a particular drug. When the radar breaks the logic of con-
versation and positions the drug at the centre as a powerful agent
around which everyday accounts are crafted, it participates in giving a
researcher a perspective from which to see. Medicine Radar pre-formats
the data for research, but also proposes an analytical emphasis. This
means that the digital device not only participates in seeing and
knowing the research data, but also advocates a research focus on the
subject matter at hand.
1.2. Emergent causalities
In terms of the social life of methods approach, digital devices can
Fig. 1. Cannabis is the most mentioned drug and pain the most mentioned symptom in the Suomi24 data.
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be regarded as materially implicated in the production and perfor-
mance of certain associations in the studied phenomenon at the expense
of others (Ruppert et al., 2013). As suggested above, Medicine Radar
advocates the study of emergent causality in terms of antidepressants
eﬀects. Meta-analyses of the discoveries from randomized controlled
trials (RCT) have questioned the eﬃcacy of antidepressants (explicitly
SSRIs) (Kirsch and Sapirstein, 1998; Kirsch et al., 2002), drawing at-
tention to their non-pharmacological and non-linear causalities (Walsh
et al., 2002; Wilson, 2008). The ingested antidepressant pill never
works in isolation, and therefore has no discrete agency all to itself
(Trivelli, 2014). The drug activates in the context of the body-mind,
through molecular-level relations that the drug forms with the drug
consumer; furthermore, it can have eﬀects even before it has been in-
gested (Wilson, 2008). This complex relationality explains how a single
drug can have such diﬀerent eﬀects. The online comments, for instance,
describe the same drug, Mirtazapine, as both a savior and a personal
hell, accentuating the ambivalent nature of the body-mind encounter:
both attraction and repulsion characterize antidepressant drug use
(Martin, 2007, 171).
How antidepressants are put to work, and how the underlying
physiological processes triggered by drugs are understood, depend on
their historical and organizational contexts (Mulinari, 2012). Sandell
(2016, 133) points to a curious paradox: whereas most pharmaceutical
companies no longer develop psychoactive drugs such as SSRIs because
the hypothesis of biological mechanisms underlining the eﬃcacy of
such drugs is not solid enough to justify further development, in pri-
mary health clinics, SSRIs are still the treatment of choice for depres-
sion – or what is believed to be depression. Diagnosis of depression –
the most common condition to result in being prescribed anti-
depressants – is historically contingent and based on descriptive
symptoms with no clear etiology (Ehrenberg, 2016; Jauho and Helén,
2018). Overall, the linkages between diagnosis, treatment and outcome
remain unstable, even if stabilizing such linkages is fundamental to
systems of drug design and approval (Dumit, 2012).
The research evidence that details major uncertainties in how de-
pression is diagnosed and antidepressants are developed, tested and
prescribed suggests that poor eﬃcacy and related emergent causalities
are established features of antidepressants, rather than anomalies. It is
thus no coincidence that it is the unstable and ambivalent aspects of
antidepressant encounters that Medicine Radar quickly discovers. For
the purposes of this study, antidepressant ‘actions’ are deﬁned in a very
speciﬁc way: the goal is to focus on emergent causalities by exploring
how antidepressant experience is shared and discussed online. When
investigating medication talk in the health-related posts of Suomi24,
the focus remains on the drug. Users of online health forums oﬀer ac-
counts of sequences of events, treatment outcomes and failures; their
depression might be diagnosed as mild, moderate, or major; it could be
deﬁned as bipolar or postnatal. Moreover, the comments describe an-
tidepressants as treatment for anxiety, panic attacks and insomnia.
Tracing drug encounters with the Medicine Radar means that even if
the human experience is foregrounded and emphasized in the online
posts alongside medicinal agencies, the vista that the radar oﬀers is
biased in favor of the medicinal agent. Thus the medicinal agency that
is discussed online is not ‘the actual’ agency of the antidepressant, but a
personal articulation of a human-drug encounter that foregrounds the
drug as an agent. When the posts address antidepressant action, they
tend to portray it as action that is caused by an ‘external agent’ that
operates all by itself. The antidepressant agency is isolated and puriﬁed,
as if the antidepressant remains separate from the body-mind where the
pill lands when ingested.
Not knowing what the medicinal agent will do to my body-mind lies
at the core of the online antidepressant experience that Medicine Radar
exposes. Despite this kind of framing, however, the goal is not to sug-
gest that an antidepressant is an entity capable of working alone; rather,
this is how the drug is perceived in action. Online posts speak about the
antidepressant from a position in the long-standing Western tradition of
subject-object division, where events and transformations are under-
stood as being caused by external forces. As Taylor (1989) suggests, our
perceptions of autonomy and dependency are deﬁned by the notion of
free will, according to which an independent agent autonomously sets
goals for action. The actions of a dependent agent, on the other hand,
are inﬂuenced by an external force disconnected from the individual. In
the case of antidepressants' becoming such external forces, it is as if
they work irrespective of the humans involved. Consequently, online
discussions say less about how the human co-evolves with the anti-
depressant than human adjustments to and expectations of the ‘pill-
Fig. 2. Medicine Radar sorts the posts according to the drug dosages mentioned.
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power’ (Trivelli, 2014, 158), understood as the potential of the pill to
inﬂuence the pill recipient. The medication is seen to open a ‘window of
opportunity’ that can restore ‘the functioning self’ (Sandell, 2016, 136)
and ‘normality’ (Fullagar, 2009, 397). The depressed is ready to sur-
render to the medicinal agency with the anticipation that the drug will
provide improvement. The posts share the disappointment felt when
the ‘pill cure’ does not work, something reﬂected in the frustrated and
negative tone of many comments. The positive aspects of anti-
depressants are, however, also apparent in discussions. Ultimately, the
comments describe how human users try to stabilize medicinal eﬀects,
as if the pill were an entity that needs to be tamed and domesticated.
This has consequences for shared antidepressant imaginaries. As dis-
cussed further below, the online comments propose that people respond
to eﬀects of the pill by observing them and adjusting to them, while
accepting that unexpected things may happen along the way.
1.2.1. Ethical questions
During our project, we evaluated the ethics of oﬀering our research
tool as an open web interface: we were aware of the questions and
controversies surrounding uses of personal data and committed to fol-
lowing the ethical principle outlined by the Association of Internet
Researchers to the eﬀect that people retain expectations of privacy
when online, which should be respected (http://aoir.org/ethics/). The
GDPR (General Data Protection Regulation) allows scientiﬁc use of
anonymous online data, and we discussed with Aller, the owner of the
Suomi24 data, how to protect their users when working with Medicine
Radar. All the Suomi24 posts have been published online prior to our
project and they are publicly accessible through search engines, mainly
Google, with no sign-in process. We have not increased the visibility of
the posts, other than by allowing them to be searched in a new way.
The open web interface is designed for key word searches that break
the logic of discussion threads, so it actually makes it more laborious to
track and identify individual writers. Medicine Radar allows the
checking of the original context of the post in the discussion thread, but
the writers remain unidentiﬁed. We could, of course, classify or seg-
ment users by carefully analyzing their comments, but this has not been
our aim. In the analysis, we concentrate on the thematic and topical
organization of the posts by exploring how antidepressant experiences
are shared and discussed online. To emphasize the topical orientation,
with the exception of some expressions, we do not cite the online
comments verbatim. The quotes oﬀered as examples are generic and
combined from more than one post. They represent anonymously pro-
duced text that provides patterned insights into the collective anti-
depressant landscape and how antidepressant experiences are shared
with others facing similar problems and outcomes. As they describe
human-drug associations, they raise more general questions about what
it means to live alongside powerful medicinal agencies and what kinds
of life eﬀects they might have.
2. Research design
2.1. One antidepressant at a time
A key word search with Medicine Radar produces a view of online
posts displayed one above the other on consecutive pages on the screen.
After an initial reading of the antidepressant posts, the empirical study
focused on three sets of posts discussing antidepressants – Mirtazapin/
Remeron and Venlafaxin. These three were chosen because of the fairly
high volume of posts (Mirtazapin 3039 posts, Remeron 1,386,
Venlafaxin 2242) and the commonplace nature of the drugs in the
treatment of anxiety and depression. Online remarks that mention
Mirtazapine produce 155 pages of material. Some posts are long and
detailed, but the majority of them are short and fairly uninformative.
With enough posts the limited information of posts starts to accumulate
into a more coherent and patterned vista of human-drug associations.
The decision to trace posts referencing individual drugs, rather than
more general antidepressant or SSRI posts, was crucial in terms of the
research design. By focusing on one drug at a time, we are not con-
fronted with more general talk linking antidepressants to gendered and
societal demands to succeed in life (Fullagar, 2009; Fullagar & O'Brien,
2012) or to institutional forces that deﬁne how drugs are developed,
designed and distributed (Martin, 2007; Dumit, 2012). Such broader
views are important in terms of antidepressant experience, but they
tend to drift away from personally felt human-drug associations
(Trivelli, 2014). When a drug is named in the post, writers typically
have a relationship with that speciﬁc drug either as users or potential
users. The intimacy of this relationship resonates with Elena Trivelli's
portrayal of the process of taking an antidepressant:
This simple ritual of drawer opening, foil clicking, resilient and re-
signed swallowing, makes a little colourful object slide down into
my stomach, ready to swim, melt, aﬀect me, change me. Make me.
(Trivelli, 2014, 159, emphasis in original)
Posts that name a certain antidepressant are written in the ﬁrst
person, either asking for advice, describing personal drug experiences
or oﬀering others advice and encouragement. They have an atmosphere
of peer support, sharing suggestions and warnings to avoid the rocky
part of trials with antidepressants. Thus, in terms of Suomi24 data,
tracing human-drug associations one drug at a time, rather than in
relation to groups of drugs (antidepressants, antibiotics, statins), ap-
pears to uncover more intimate and less certain aspects of anti-
depressant encounters, following experiences closer to the bodies, and
recognizing the eﬃciencies and ineﬃciencies of medicinal agencies. As
argued below, this draws attention to the recurring nature of private
details of the human-drug relationship, suggesting a focus on repeated
reactions to antidepressant eﬀects.
2.2. Articulating reactions to life eﬀects
Seeking a patterned vista to antidepressant encounters, two research
assistants ﬁrst sorted Mirtazapine/Remeron and Venlafaxin posts ac-
cording to three phases: starting the medication, struggles with the
antidepressant and discoveries concerning the human-drug balance.
Narrative framings have arranged earlier studies, underlining how the
act of taking medication activates a sequence of events that at some
point ﬁnds its resolution, either in parting ways with the anti-
depressant, or integrating the medicinal regimen into the everyday for
years to come, either permanently or periodically (Gibson et al., 2014;
Sandell, 2016; Trivelli, 2014). The hardships of the ﬁrst days of the
regimen conﬁrm that the drug can cause major disturbance to the body-
mind, suggesting an empirical focus on stabilizing the human-drug re-
lationship (McLeod, 2014; Weiner and Will, 2016). Following more
closely the stabilization of human-drug encounters in the online com-
ments, discussed in greater detail below, gives rise to the proposal that
antidepressant engagements are not linear and straightforward, but
rather messy. Antidepressant eﬀects are physiological, but also inﬂu-
enced by factors discussed under the rubric of themes such as ‘non-
pharmacodynamic milieu’ (see, Wilson, 2008, 38). Human-anti-
depressant associations remain both varied and diﬃcult to isolate
(Wilson, 2008). Antidepressants are taken one at a time, but also si-
multaneously, then stopped because of felt side eﬀects, stopped and
changed to another antidepressant, stopped and restarted with a
smaller or bigger dose, or stopped and replaced by alcohol or illicit
drugs. With this kind of multiplicity, we needed to modify our ap-
proach. We kept the three part structure of exploration, but modiﬁed it
so as not to arrange the posts according to three phases of a sequence,
but as three responses to the irregular and disruptive agencies of anti-
depressants.
In its second iteration, the empirical work focused on the explora-
tion of the topical organization of the posts by reading them through
and tracing ways in which eﬃciencies and ineﬃciencies of anti-
depressants were discussed and dealt with. We explored more closely
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the stabilization of the human-drug relationship, which proved to be a
prominent feature of the online conversations.
Along with this, posts describe recurring trials and errors and the
disappointment of not ﬁnding a medicinal repair, explaining why posts
gravitate towards the negative eﬀects of antidepressants. As in inter-
views, the posts discuss the qualities of medicinal agencies that restore
the ability to function in the everyday (Sandell, 2016), but they also
describe the worst aspects of antidepressant associations. In the case of
Mirtazapin, nicknamed ‘the fattening pill’ in the posts, the leaﬂet inside
the package lists increased appetite, weight gain, drowsiness and diz-
ziness as side eﬀects. Those of Venlafaxin include anxiety, shaking,
sleep problems and increased sweating. Similarly, posts describe in-
satiable appetite, tiredness, agitation and emotional numbness. The
sweating caused by Venlafaxin can become so intense that bedlinen
must be changed in the middle of the night.
The focus on emerging causalities of antidepressants and their un-
ruly and non-linear nature pushed us towards exploration of the life
eﬀects of antidepressants. The term ‘side eﬀect’ suggests the possibility
of circumventing or sidelining the undesired eﬀects of a drug, but many
comments forcefully challenge this idea, suggesting that side eﬀects
need to be explored as life eﬀects. Being attentive to ‘life eﬀects’ while
reading the posts meant that we concentrated on ﬁnding the topical and
thematic commonalities in how antidepressants shape and shatter life
and how people respond to that. This led to the ﬁnal framing of the
empirical analysis, focusing on how antidepressant eﬀects are either
stabilized or seen to operate as external forces that possess powers that
the human can only observe. As external forces, antidepressants are
seen to have life eﬀects that cannot be withstood. The nonhuman agent,
the pill, is in charge, while the human merely observes and waits for the
human-drug relationship to balance and improve with time. The fail-
ures of such balancing explain why dosages are altered and medication
use is terminated. The ultimate powers of antidepressants become vi-
vidly evident in posts that describe how people are trying to part ways
with the drug, or how they come to terms with the life eﬀects of anti-
depressants and eventually see them as an inescapable part of existence.
3. Findings
3.1. Stabilizing antidepressant eﬀects
The posts that discuss the selected antidepressants do not question
the received prescriptions, but they do question the antidepressant ef-
fects with which the users will soon be confronted: Is it true that I will
gain weight? Will I become sleepy and torpid? Will I be able to work? The
repeated questions in the online comments stress that antidepressants
are known to be irregular and unruly agents, producing eﬀects that
cannot be fully anticipated. Posts ask advice on how to prepare for the
unknown, while the more experienced writers share tips to confront the
emerging causalities of the drugs. At ﬁrst, they explain, Mirtazapin
causes daytime sleepiness and makes one torpid. And yes, it increases
the appetite, but when you acknowledge that and keep your eating
rigorously under control, the weight does not increase by more than a
couple of kilograms.
As is typical for online forums, posts oﬀered for peer support are
written as advice: ‘At ﬁrst you might feel rotten, but after taking the
antidepressant for a couple of weeks, or some months, you will notice
what a good drug it is.’ The peer advice focuses on relieving the pain of
others, translating into practical assistance and encouragement to ease
human-drug collaboration: ‘Once the drug start to function properly,
your mood will improve and everyday powers will be recovered.’ The
advice given underlines how the eﬀects of the medicinal agent can be
controlled, stabilized and domesticated with patience and will power.
The role of the human agent is underscored: ‘Don't get nervous if you
feel very torpid after two-three days of starting, it will pass!’ The shared
conviction here is that the initial side eﬀects are worth enduring.
The work of stabilizing the human-drug relationship has not gone
unnoticed in earlier research (McLeod, 2014; Weiner and Will, 2016).
On a concrete level, it involves developing a daily routine of pill taking.
The pills need to be kept in an easily accessible place in the handbag, on
the bathroom shelf or in the bedside drawer (McLeod, 2014). The ad-
vice given online normalizes the idea that it takes time before medicinal
agencies are properly tamed. The human needs to be prepared for this,
and to learn ways to adjust to the pill-power. Given that starting the
medication can have eﬀects that disturb everyday work routines, it
might be a good idea to practice with the medication on a day oﬀ, or
over the weekend. The posts even share tips on how to halve the tablets:
with dry hands and a sharp knife, otherwise the tablet will melt. If you
take the medicine too late in the evening, the posts point out, it is hard
to get up the next morning and the whole day goes by in a bit of a fog.
The online comments are concrete reminders of how personal the
eﬀects of drugs are. Furthermore, it seems not uncommon for anti-
depressants not to be taken in the prescribed manner. Practices of
stabilizing everyday life with medicinal agencies involve lowering the
dose, taking them less frequently or taking ‘drug holidays’ (Pound et al.,
2005, 152). In the case of preventive medication like statins, people
move between use and non-use with relative ease (Weiner and Will,
2016). With antidepressants, however, the transitioning between use
and non-use can trigger unpleasant, even agonizing withdrawal symp-
toms, with the result that medicinal agencies are not tinkered with as
eﬀortlessly. Still, in light of the antidepressant posts, people appear to
be exercising agency over medicinal agencies by regulating the dosages
taken and experimenting with them. Mirtazapin posts discuss lowering
the dosage when better sleep is the goal, but increasing it to combat
depression: in terms of sleep the best dosage is said to be less than
15mg, it could even be as low as 2mg. Indeed, antidepressants are
consumed as ‘crumbs’ when the aim is to secure sleep. The posts also
reiterate the importance of the body size of the individual taking the
drug: for a petite young woman, a 15mg dosage can be enough, while
large men can take 45mg. Thus it is no coincidence that the online
posts are detailed when it comes to dosages, underlining that the
agency of the drug can be controlled, if the dosage is right, for the
individual and for the condition.
3.2. Observing life eﬀects
While stabilizing the human-drug relationship refers to active re-
sponses to antidepressant eﬀects, another kind of patterned response to
the emergent causalities of antidepressants portrays the human at the
mercy of the antidepressant; it is the drug rather than the human that
possesses the power to set the goals for action. When writing the pre-
scription, the doctor might have mentioned the possibility of increased
appetite, a known side eﬀect of the drug, but the drug user is still ill-
prepared for what lies ahead. Comments describe how the eﬀects of
drugs shape the everyday: relentless appetite and the impossibility of
sleeping due to thoughts about the contents of the larder and what to
eat are common symptoms. At night, people ﬁnd themselves standing in
front of the refrigerator, wolﬁng down whatever they ﬁnd. Posts appear
exaggerated, mentioning a 10 kg weight gain in under two months,
despite a strict exercise regimen. The newly gained kilograms ‘settle on
the thighs’ and the stomach, producing ‘a puﬀy ruin’, as one Mirtazapin
user claims.
Antidepressant agencies capture and shape the bodies and minds,
the posts appear to be saying. The kilograms gained are framed as
warning signs. ‘Do not touch Mirtazapin, even if it is recommended
(weight gain 12 kg).’ The new body shape is described with resentment:
the stomach hangs over the pants and clothes no longer ﬁt. Rather than
factual descriptions of human-drug encounters, the comments seem like
personal articulations of lost autonomy. They portray the anti-
depressant as an external force disconnected from the individual, of-
fering personal records of how the ‘medication works on the body’, as
Sandell puts it (2016, 138). Reading individual accounts of depression
closely, Sandell (2016) suggests that biology has become a destiny for
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the depressed, who no longer try to make sense of their depression but,
rather, treat it as a condition that is unexplainable and empty of
meaning. Similarly, antidepressants possess powers that cannot be
shaped or fought: the medicine triggers eﬀects that one can merely
observe.
The medicinal agent – rather than the body – appears as a ﬂexible
and malleable force in drug-related comments, producing variations in
moods and bodily functioning depending on the body-mind on which it
is exercising its agency. Since they emphasize the problematic aspects
of human-drug encounters, the posts detail dramatic variations rather
than a causal linearity of good antidepressant action. For instance,
problematic encounters with Remeron, ‘rat poison’ as one of the posts
calls it, include feelings of being paralyzed, with legs that no longer
function, a sense of being drunk and therefore afraid to drive, a sen-
sation of electric shocks in the head and not being able to keep still
while trying to go to sleep. The drug is also said to cause people to
become so muddled that, waking in the night, they enter the closet
instead of going to the bathroom. Earlier studies argue that anti-
depressants challenge the sense of self by generating ‘a mental anes-
thetic’ (Schoﬁeld et al., 2011, 145) and making people feel emotionally
numb (Sandell and Bornäs, 2017). Similarly, one of the posts vividly
describes ‘a chemical lobotomy’. By detailing responses to medicinal
agencies, online comments oﬀer experiential weight to how emotion-
ally and physically challenged one might feel with antidepressants. The
online forum is a place of co-journeying, where people can anon-
ymously voice their concerns and discuss how unbearable and mad-
dening the life eﬀects of antidepressants are. On the other hand, how-
ever, posts also talk about drugs having no eﬀect. People wait to
observe life eﬀects, but can detect no change other than being ex-
tremely tired. The antidepressant experience remains a ‘puzzle of mind-
body aﬃliation’ (Wilson, 2008, 39).
3.3. Coming to terms with life eﬀects
The third identiﬁed response to human-antidepressant associations
portrays the drug as an ally rather than an enemy. This involves coming
to terms with the life eﬀects of antidepressants. Before getting there,
however, antidepressants might be abandoned either in the short term,
or for good. Comments that discuss setting limits to pill-power by ter-
minating antidepressant use make it clear that becoming reconciled
with the life eﬀects of antidepressants might not be possible. Emergent
causalities of antidepressants, becoming emotionally numb or losing
sexual desire, are typical reasons for ending medication (Schoﬁeld
et al., 2011). The posts that advise on how to part ways with the an-
tidepressant convey a human-drug symbiosis in which the body has
adjusted to the drug; if the two are separated, the chemistry of the body
gets messed up. Experiences of antidepressant withdrawal are narrated
as the human battling against pill-power. Comments underline how the
withdrawal needs to be conducted with care, by cautiously lowering the
dose and with careful monitoring. Yet, even if people try to lower the
dosage gradually, withdrawal symptoms may be unbearable: intense
nausea is felt, electric shock waves go through the body, sleep becomes
unattainable and anxiety and depression return immediately after the
eﬀects of the medicine dissipate.
The posts also speak of abrupt endings, of decisions to stop the
medication, once and for all. This happens when the will to limit the
pill-power is greater than the fear of the eﬀects of giving up the drug.
Descriptions of withdrawal symptoms end with appropriate warnings:
‘Never start antidepressants, if you want to avoid this hell.’ Successful
withdrawals from drugs are celebrated with descriptions of looking
more natural, thinking more clearly and feeling both positive and ne-
gative emotions. On the other hand, the posts point out that if life does
not rebalance within a reasonable time after stopping the anti-
depressants, or if the anxiety, depression or insomnia return, one can
always resume medication. Online comments can look like reviews,
listing medications and their combinations, and comparing their
strengths and weaknesses. A person's ‘anti-depressant career’ might
mean being exposed to one pill after another, or simultaneously;
meanwhile, some medications produce better combinations and results
than others.
Ultimately, however, if such tinkering is unsuccessful, and the op-
tion of stopping the antidepressants has failed, sometimes the only
course of action left is to stop trying to limit the pill-power, and accept
human-drug associations as a permanent part of everyday life. In other
words, one must come to terms with the life eﬀects and learn to live
with them. Even if it might be emotionally healthier to do without
antidepressants, resulting in no longer feeling like ‘a robot’ or ‘a ma-
chine’ (Sandell and Bornäs, 2017), it might not be possible. As Sandell
(2016, 139) argues, a person's depression may not be curable, merely
managed, with antidepressants becoming life companions. If someone
cannot function in the structures of daily life, ‘capsules of potentialities’
(Trivelli, 2014, 159) can be of assistance. The drug becomes framed as a
handmaid that maintains the everyday operation of the self. The life
eﬀects of the drug, resulting in no longer being able to laugh naturally
or leaving life a ‘dull grey’, are still a better option than not being able
to get up in the morning and take care of everyday tasks. Coming to
terms with antidepressants can mean that drugs are ‘for life’ (Dumit,
2012).
4. Discussion
4.1. Politicizing life eﬀects
In making aspects of antidepressant experiences visible, Medicine
Radar works as a researcher's ally in detecting the emergent causality of
antidepressants. The manner in which the radar portrays recurring
features of human-antidepressant associations breaks the logic of online
peer talk and positions antidepressants at the centre of attention as
powerful agents that oblige humans to respond to their eﬀects. The
radar is implicated in knowledge formation by directing empirical ex-
ploration in a way that disassembles personal articulations of anti-
depressant experiences into medicine-triggered responses.
Consequently, the antidepressant experience can be divided into three
responses to felt life eﬀects of antidepressants – stabilizing them, merely
observing them or coming to terms with them – that engage with pre-
vious qualitative studies from diverse perspectives.
The empirical analysis presented makes the selective manner in
which the radar treats online conversations very evident: it promotes a
drug-centric perspective, demonstrating how medicinal agencies op-
erate on pill-power. On the other hand, reading the online comments
and learning how writers articulate their antidepressant experiences
balances the machinic view that the radar oﬀers. Comments reveal
personal experiences with reﬂective powers that aid in describing and
managing the vagaries of the human-drug relationship. By articulating
antidepressant eﬀects, personal hardships with medication are trans-
formed into a more conscious human-drug relationship and connection
with others (Schoﬁeld et al., 2011, 145). Online, experience gained
through trial and error with antidepressants oﬀers the possibility of
establishing ‘experiential authority’ (Fullagar, 2009, 404), suggesting
credibility as a peer mentor and an online inﬂuencer (McCosker, 2018,
9–10).
With the focus on the ﬁrst-person drug encounter, the ﬁndings of
this study add to earlier qualitative research, suggesting that digital
datasets – no matter how large they are – might not uncover entirely
novel aspects of everyday medicinal encounters. By disassembling and
reshuﬄing digital traces, the radar can, however, participate in pre-
senting such encounters in a way that deepens earlier ﬁndings with
additional detail. The unsolicited nature of digital datasets not only
allows the exploration of sensitive aspects of drug use shared online,
but it oﬀers them collective weight. Medicine Radar pushes us to see
collectively shared features of human-antidepressant experience more
clearly. With its computational powers, the radar promotes a mode of
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observation that begins by locating ﬁrst-person accounts by tracing the
drug and then allows the accounts to grow into a multi-ﬁrst-person
landscape – an n of many ones (Nafus, 2017). In terms of the multi-ﬁrst-
person landscape, comments that mention a particular drug are of key
importance, because they contain intimate knowledge of the life eﬀects
of speciﬁc drugs, adding to the analysis of recurring responses to an-
tidepressant agencies and pill-power. The multi-ﬁrst-person landscape
calls for seeing beyond the individual, giving form to the felt life eﬀects
of antidepressants and ultimately raising more general questions about
medicinal agencies and how they should be dealt with collectively.
Following Bennett (2010), the focus on the agency of drugs pulls
them into the domain of politics, proposing that political theory should
concern itself with the material world. The ﬁrst step in this direction
requires that the powers and eﬀects of medicinal agencies be collec-
tively acknowledged. The online conversations testify to powerful
nonhuman agencies that should not be engaged with lightly. In their
articulation of life eﬀects, the posts amplify negative and frustrating
antidepressant experiences, but their emotional and exaggerated tone is
no reason to downplay their overall message of the shakiness of the
human-drug relationship. Articulations of antidepressant encounters
stress the instabilities of medicinal agents and call for their evaluation
in light of the relations they form with contemporary health care ar-
rangements, forcefully challenging the normalization of antidepressants
in terms of mental health care. The ﬂaws, inconsistencies and dis-
turbing life eﬀects of antidepressants which have been the focus of this
study are widely acknowledged both in research and in the online
conversations. Tellingly, some of the writers wonder about the eager-
ness of doctors to prescribe antidepressants without considering their
everyday consequences, as if it were completely normal and acceptable
that the antidepressant user must endure the disturbing eﬀects the
drugs have on their lives. Signiﬁcantly, there is no discussion of any
diﬃculty in getting access to antidepressants; the drugs appear to be
plentiful. As the posts point out, you just need to ask.
Sandell (2016, 145) notes that psychiatrists have lost control of
antidepressants – they can be prescribed by any doctor, with no parti-
cular expertise in mental health, based on brief consultations, without
treatment plans or follow-ups. A focus on collective responses to anti-
depressant eﬀects can be seen as an ethical rather than a political
stance, merely seeking to acknowledge the unruly nature of anti-
depressant agencies, while avoiding the responsibilization of the
pharmaceutical industry, or the critical assessment of the politics and
economics of health care arrangements (Lemke, 2018). To formulate a
more robust political stance, a formal agenda is needed in order to
question the social and economic factors that condition antidepressant
use. The crucial ﬁrst step is taken, however, when the pill powers of
antidepressants and their life eﬀects are collectively acknowledged.
4.2. Afterlife of the radar
The current version of Medicine Radar is a prototype with plans to
update the Suomi24 dataset and improve the used vocabularies.
Missing keywords can be reported online, so that they can be taken into
account once the tool is revised. As a prototype that calls for further
development, the social life of Medicine Radar is in its infancy, so far
oﬀering suggestions for reducing and sorting online health-related data
in social scientiﬁc inquiry. With the open source resources that we
oﬀer, similar computational tools could be developed for organizing
other kinds of digital datasets. Our approach is not language speciﬁc,
although language speciﬁcities need to be taken into account. Further
developments of the radar could involve functionalities that allow the
visualization of the temporality of the posts. That way we could see
when the drug talk has been most intense, but also when it dies down.
More could also be done in terms of the analysis of comments. In this
study, the empirical work relied on rounds of reading and sorting the
material, but the analysis could be supported with additional technical
features. In future versions of Medicine Radar, the medical concepts
should not only be correlated with symptoms and dosages, but also with
concepts related to the health care profession (doctor, diagnosis, pre-
scription, care, hospital), in order to learn how prescriptions and doc-
tors feature in the medication talk and whether health care profes-
sionals are as absent from antidepressant experiences as they appear in
light of this study.
Isolating the drug from the body-mind is a technique that allows
exploration of the agency of medications. Yet it should not be forgotten
that medicines never act alone. Antidepressants are relational in their
agencies and have eﬀects both before they enter the body and after they
leave it (Wilson, 2008; Bennett, 2010). The normalization of long-term
antidepressant use has consequences for the depressed, but also for the
nonhumans with whom we live: the mammals, ﬁsh and crustaceans in
the oceans that are also being exposed to pill-power. Bennett (2015, 84)
calls for transforming modes of consumption into their opposites; in the
case of antidepressants one way forward would be to demand more
mechanical causality from antidepressant agencies. With less trial and
error in terms of antidepressant use, their overall consumption would
not only decrease, but generate fewer undesired life eﬀects.
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